Precision Optics (POCI)

Search documents
LaCroix Precision Optics Expands in Batesville, Arkansas, Creating 107 New Jobs
GlobeNewswire News Room· 2025-06-05 18:17
BATESVILLE, Ark., June 05, 2025 (GLOBE NEWSWIRE) -- LaCroix Precision Optics announced that it will be expanding its manufacturing operations in Batesville, Arkansas, creating 107 new jobs over five years. The company will be investing $13.8 million as part of the expansion. “LaCroix Precision Optics is excited to expand our operations in Batesville, Arkansas to support a multi-year military contract that will help restore a critical supply chain to the United States,” said Kirk Warden, President of LaCroix ...
Precision Optics Expands Facilities to Meet Growing Backlog
Globenewswire· 2025-06-05 13:00
Company signs lease to move corporate offices and engineering development to Littleton, MA Move allows for expansion of production capabilities in Gardner, MA to meet increased backlog GARDNER, Mass. and LITTLETON, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced it has made the strategic decision to move its corporat ...
Precision Optics Corporation (POCI) 2025 Conference Transcript
2025-05-29 15:15
Summary of Precision Optics Corporation (POCI) Conference Call Company Overview - **Company Name**: Precision Optics Corporation (POCI) - **Ticker Symbol**: POCI, traded on NASDAQ - **Industry**: Optical systems design and manufacturing, focusing on medical devices and defense aerospace applications [2][3] Core Business Model - **Business Model**: Develops technology in optical systems, collaborates with customers to design products, and handles manufacturing [4][5] - **Revenue Growth**: Recent transition from product development to manufacturing is expected to significantly impact revenue positively [6][8] Financial Performance - **Revenue Trends**: Revenue has shown continuous growth over the past seven to eight years, with a slight pullback from fiscal 2023 to 2024 due to legacy products going end of life [7][30] - **Fiscal Year**: Fiscal year runs from July 1 to June 30, with expectations of revenue growth resuming towards the end of fiscal 2025 and into 2026 [8][30] - **Gross Margins**: Historically between 30% to 40%, currently lower due to startup challenges with new programs, with a target to return to 40% [31] - **Adjusted EBITDA**: Expected to reach $6 million in the current quarter, indicating a revenue run rate of $24 million, which would surpass breakeven [32][47] Key Technologies and Markets - **Micro Optics**: Focus on small optics for medical devices, particularly endoscopic systems [8][9] - **3D Imaging**: Development of high-precision imaging systems, including UHD and 3D endoscopes [10][14] - **Digital Imaging**: Integration of CMOS sensor technology into medical devices, enabling single-use endoscopes that enhance safety and reduce sterilization concerns [15][16][17] - **Market Segments**: - **Medical Devices**: Major focus area, contributing significantly to revenue [12][17] - **Defense Aerospace**: Represents about 30% of revenue, with opportunities in smaller optics for military applications [18][19] Production and Operational Challenges - **Production Ramp-Up**: Transitioning to larger volume production has faced challenges, including initial yield issues, particularly with the single-use cystoscope production line [36][38] - **Current Status**: Production rates have doubled since resolving initial challenges, with expectations for continued increases [39][42] Future Outlook and Strategy - **Pipeline Development**: Targeting two to four new programs to move into production each year, with several programs expected to commercialize in the next twelve months [50][52] - **Expansion Plans**: Plans to expand production capabilities and update facilities to support growth [28][29] - **Acquisition Strategy**: Continues to look for opportunistic acquisitions that align with technical synergies [30] Conclusion - **Positive Outlook**: The company is at an inflection point with strong customer demand and a focus on executing manufacturing processes, anticipating significant revenue growth in the near future [58][59]
Precision Optics to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Globenewswire· 2025-05-27 20:15
Core Viewpoint - Precision Optics Corporation will participate in the Lytham Partners Spring 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on May 29, 2025 [1][2][3]. Company Overview - Founded in 1982, Precision Optics is a vertically integrated optics company focused on advanced optical instruments for the medical and defense/aerospace industries [4]. - The company leverages proprietary micro-optics, 3D imaging, and digital imaging technologies to provide services from product concept to mass manufacture [4]. - Precision Optics supports next-generation medical device companies by providing enhanced imaging systems for minimally invasive surgery and 3D endoscopy systems [4]. - The company has a long history of supplying optical products, including complex endocouplers and specialized endoscopes, to top-tier medical device companies [4]. - In the defense/aerospace sector, Precision Optics applies its technical proficiency in micro-optics to meet high-quality standards while optimizing size, weight, and power [4].
Precision Optics Corporation, Inc. (POCI) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-05-16 00:34
Call Start: 17:00 January 1, 0000 5:41 PM ET Precision Optics Corporation, Inc. (NASDAQ:POCI) Q3 2025 Earnings Conference Call May 15, 2025, 05:00 PM ET Company Participants Robert Blum - IR, Lytham Partners Joe Forkey - Chief Executive Officer Wayne Coll - Chief Financial Officer Conference Call Participants Operator Good day, and welcome to the Precision Optics Third Quarter Fiscal Year 2025 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please not ...
Precision Optics (POCI) - 2025 Q3 - Earnings Call Transcript
2025-05-15 22:02
Precision Optics Corporation (POCI) Q3 2025 Earnings Call May 15, 2025 05:00 PM ET Company Participants Robert Blum - Managing PartnerJoseph Forkey - CEO & PresidentWayne Coll - CFO & Secretary Conference Call Participants None - Analyst None Welcome to the Precipio First Quarter twenty twenty five Shareholder Update Conference Call. All participants will be in listen only mode. Please note that the conference is being recorded. Statements made during this call contain forward looking statements about our b ...
Precision Optics (POCI) - 2025 Q3 - Earnings Call Transcript
2025-05-15 22:00
Precision Optics Corporation (POCI) Q3 2025 Earnings Call May 15, 2025 05:00 PM ET Speaker0 Welcome to the Precipio First Quarter twenty twenty five Shareholder Update Conference Call. All participants will be in listen only mode. Please note that the conference is being recorded. Statements made during this call contain forward looking statements about our business. You should not place undue reliance on forward looking statements as based upon our current expectations, forecasts and assumptions. Speaker1 ...
Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
GlobeNewswire News Room· 2025-05-15 20:30
GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its third quarter fiscal year 2025 for the period ended March 31, 2025. Q3 2025 Financial Highlights (3 Months Ended March 31, 2025): Revenue was $4.2 million compared to $5.2 million in the same quarter of the previous fiscal year and comp ...
Precision Optics (POCI) - 2025 Q3 - Quarterly Report
2025-05-15 20:15
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-10647 PRECISION OPTICS CORPORATION, INC. (Exact name of registrant as specified in its charter) Massachusetts 04-2795294 ...
Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025
Globenewswire· 2025-05-08 20:15
GARDNER, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s third quarter fiscal year 2025 financial results on Thursday, May 15, 2025, at 5:00 p.m. ET. The Company intends to release its financial results and to file its 10-Q after the close of the market ...